ClinicalTrials.gg
RecruitingNCT06275516Updated Nov 16, 2026

Safety and Efficacy of Multisensory Stimulation Virtual Reality for Stroke Patients.

An interventional study of multi-sensory stimulation immersive VR+ treadmill training and treadmill training in Stroke, sponsored by First Affiliated Hospital of Chongqing Medical University. Recruiting at 1 site in China. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by First Affiliated Hospital of Chongqing Medical University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Updated Nov 16, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 613 studies in Stroke with a site in China — 242 open to participants now, 263 under way, 21 of them phase 3. Stroke · China.

Planned enrollment
371st of 432
40 · median 169
Started
2024
with 70 others
No phase
264 of 613
123 open now
Primary completion
2026-12
later than 120 of 262 live
Registered
395th of 613
by date

Among the 613 studies in Stroke with a site in China, this one is the 371st largest by planned enrollment of the 432 interventional ones that give a count, is one of 71 that started in 2024, is one of 264 with no phase, reaches primary completion later than 120 of the 262 other live ones, and was the 395th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

242 of the 613 studies in Stroke with a site in China are open now. Recruiting first, the newest first:

237 more — sign in →

All 242 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 613 studies in Stroke with a site in China, or all of them as a file.
02

Study summary

This was a single-blind randomized controlled trial of multisensory stimulation virtual reality to improve motor and cognitive dysfunction in stroke patients.

Read the detailed description

This was single-blind randomized controlled intervention study. Each stroke subject underwent screening period, baseline assessment period, intervention period, endpoint assessment period.

The screening period include the verification of inclusion/exclusion criteria and the acquisition of informed consent.

Baseline and endpoint assessment period include motor function related scales were evaluated (muscle strength, muscle tone, Fugl-Meyer scale, Berg balance scale); cognitive function related scale assessment [Brief Mental State Examination Scale (MMSE), Montreal Cognitive Assessment (MoCA), drawing clock test, Shape connection test A.B, standardized digital modal experiment, auditory word Learning Test], emotional correlation scale assessment (Hamilton Depression Scale, Hamilton Anxiety Scale), and activity of daily living scale ADL scale. Meanwhile, quantitative evaluation of motor function three-dimensional gait detection and assessment of brain functional activation (fNIRs tests and fMRI) were synchronously completed.

The intervention period included multi-sensory stimulation immersive VR+ treadmill training with suitable for training intensity in the experimental group and only treadmill training similarly with suitable for training intensity in the control group. 20 minutes a day for 30 days, a total of 600 minutes (training frequency is adjusted according to the patient's own conditions).

Preliminary validation of effectiveness assessment includes Fugl-Meyer scale, Berg balance scale, and three-dimensional gait detection. Preliminary validation of the safety assessment includes fall and dizzy incidents.

In addition to the routine baseline assessments, an real-time multisensory assessment involving healthy volunteers and stroke patients will be conducted to investigate immediate cortical hemodynamic responses and gait adaptations under different virtual reality (VR) sensory stimulation conditions. During treadmill walking, participants will undergo standardized visual and audiovisual stimulation conditions. Functional near-infrared spectroscopy (fNIRS) and quantitative gait measurements will be employed. These assessments will be analyzed separately and will not affect the original randomized allocation, rehabilitation interventions, or primary outcome of the clinical trial.

03

Conditions studied

  • Stroke

Browse trials for

04

Who can participate

The criteria were revised on the registry on Nov 16, 2026. See what changed

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  1. The first onset of stroke is diagnosed and confirmed according to the requirements of stroke
  2. The Fugl-Meyer Assessment of Lower Extremity (FMA-LE) is less than 34.
  3. 18-85 years of age.
  4. Able to walk with minor assistance
  5. score of 20-30 and ability to understand and follow instructions during the trial
  6. Able to sign an form.

Exclusion Criteria:

  1. Severe visual or hearing impairments.
  2. Pregnant or breastfeeding women.
  3. Patients with unrepaired cranial bone flaps or metallic implants following brain surgery.
  4. Presence of other conditions affecting lower limb motor function, such as osteoarthritis or recent lower limb fractures.
  5. History of severe psychiatric disorders, other neurological diseases, acute cardiopulmonary dysfunction, multiple organ failure, brain tumours, or epilepsy.

Healthy Volunteers

Inclusion Criteria:

  1. Age 18-85 years.
  2. Normal or corrected-to-normal vision and normal bilateral hearing.
  3. Ability to walk continuously on a treadmill without assistance for at least 30 minutes.
  4. Voluntary participation and provision of written informed consent.

Exclusion Criteria:

  1. History of stroke, neurological disorders affecting cognitive or motor function, or severe psychiatric illness.
  2. Lower-limb musculoskeletal disorders, recent major injury or surgery, or other conditions that may interfere with normal walking.
  3. Severe cardiopulmonary disease or any unstable medical condition.
  4. Skull defects or cranial metallic or electronic implants that may interfere with fNIRS optode placement or signal acquisition.
  5. Pregnancy or breastfeeding.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    VR+treadmill training group

    Multi-sensory stimulation immersive VR+ treadmill training with suitable for training intensity. 20 minutes a day for 30 days, a total of 600 minutes (training frequency is adjusted according to the patient's own conditions).

    Device: multi-sensory stimulation immersive VR+ treadmill training

  • Active comparator
    treadmill training group

    Only treadmill training similarly with suitable for training intensity in the control group. 20 minutes a day for 30 days, a total of 600 minutes (training frequency is adjusted according to the patient's own conditions).

    Device: treadmill training

Interventions

  • Devicemulti-sensory stimulation immersive VR+ treadmill training

    Treadmill training with multi-sensory stimulation immersive VR in VR+treadmill training group

  • Devicetreadmill training

    Only treadmill training in treadmill training group

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Assessment- Lower Extremity

    The Fugl-Meyer Assessment of Motor Recovery after Stroke - Lower Extremity (FMA-LE) evaluates lower extremity motor impairment through 17 items assessing reflexes, synergy patterns, and coordination. Each item is scored 0-2 (total range 0-34), with higher scores indicating better motor function. The total is the sum of all items, including motor (0-30) and coordination (0-4) subcomponents.

    Time frame: 30 days (Adjust according to the actual situation of patients)

Secondary outcomes

  1. Functional Near-Infrared Spectroscopy Detection - Supplementary Motor Area - Oxygenated Hemoglobin (fNIRS Detection - SMA - HbO2)

    Functional Near-Infrared Spectroscopy Detection - Supplementary Motor Area - Oxygenated Hemoglobin (fNIRS Detection - SMA - HbO2) measures cortical activation in the supplementary motor area via oxygenated hemoglobin concentration changes. Values are reported as changes from baseline in mmol/L, with increases indicating greater neural activity during motor tasks.

    Time frame: 30 days (Adjust according to the actual situation of patients)

  2. Berg balance scale

    Berg Balance Scale (BBS) is a 14-item performance-based measure that assesses static and dynamic balance abilities in older adults or individuals with impaired balance function. Each item is rated on a 5-point ordinal scale ranging from 0 (unable to perform) to 4 (able to perform independently), yielding a total score range of 0 to 56, with higher scores indicating better balance and lower fall risk. The total score is calculated by summing all 14 individual item scores, and it is commonly used to evaluate balance impairment and predict fall risk in clinical populations.

    Time frame: 30 days (Adjust according to the actual situation of patients)

  3. 3D Gait Analysis - Affected Side Step Width

    3D Gait Analysis - Affected Side Step Width: This parameter measures the lateral distance between the two feet during walking, derived from three-dimensional motion analysis, focusing on the affected side. Units are centimeters (cm), with typical values ranging from approximately 5 to 20 cm depending on individual factors. Higher values represent wider step width, which may indicate balance deficits or compensatory strategies; lower values may also reflect instability. The clinical interpretation of better or worse outcomes is context-dependent.

    Time frame: 30 days (Adjust according to the actual situation of patients)

  4. Montreal Cognitive Assessment(MoCA)

    Montreal Cognitive Assessment (MoCA) is a brief screening tool for mild cognitive impairment, evaluating visuospatial/executive function, naming, memory, attention, language, abstraction, delayed recall, and orientation. It comprises 30 items with a total score range of 0 to 30, where higher scores indicate better cognitive function (≥26 considered normal). The total is the sum of all subdomain scores.

    Time frame: 30 days (Adjust according to the actual situation of patients)

  5. Mini-Mental State Examination (MMSE)

    Mini-Mental State Examination (MMSE) is a brief cognitive screening tool assessing orientation, registration, attention and calculation, recall, language, and visual construction. It consists of 30 items with a total score range of 0 to 30, where higher scores indicate better cognitive function (scores ≥24 are generally considered normal). The total score is calculated by summing all item scores.

    Time frame: 30 days (Adjust according to the actual situation of patients)

Other outcomes

  1. Fall incidents

    Safety assessment

    Time frame: 30 days (Adjust according to the actual situation of patients)

  2. Dizzy incidents

    Safety assessment

    Time frame: 30 days (Adjust according to the actual situation of patients)

07

Study locations

1 of 1 sites recruiting
  • The First Affiliated Hospital of Chongqing Medical University, First Branch
    Chongqing, Chongqing Municipality 400016, China
    Recruiting
08

References and documents

Publications

  • Yang Z, Lu Q, Chen D, Tang L, Ran T, Yang L, Bai D. Multidimensional effects of virtual reality on motor dysfunction in patients who had a stroke: study protocol for a prospective, randomised, controlled clinical trial. BMJ Open. 2026 Apr 3;16(4):e108362. doi: 10.1136/bmjopen-2025-108362. PubMed 41932701 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — The deidentified individual participant data (IPD) that underlie the results reported in this study will be available beginning 6 months and ending 5 years after publication. Data will be shared with researchers who provide a methodologically sound proposal for use in individual participant data meta-analysis or replication of study findings. Proposals should be directed to corresponding author's email. To gain access, data requestors will need to sign a data access agreement.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: 2027.6.30

Access criteria: Access Criteria: Data will be available to researchers who submit a scientifically sound proposal. Requestors must agree to use the data only for the stated research purpose and sign a data access agreement. Ethical approval may be required depending on the proposed study.

Data sharing details ↗ · figshare.com

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Dec 2026, 33 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 33 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jun 2026 → Dec 2026 and completion Jul 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2024
First posted
Feb 23, 2024
StartActual
Mar 20, 2024
Primary completionEst.
Dec 30, 2026was Jun 2026
CompletionEst.
Dec 30, 2026was Jul 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 30, 2026→Dec 30, 2026
Nov 16, 2026
Study completion
Jul 30, 2026→Dec 30, 2026
Nov 16, 2026
Eligibility
14 criteria added
What changed in the criteria
  • AddedInclusion Criteria:
  • AddedExclusion Criteria:
  • AddedHealthy Volunteers
  • AddedInclusion Criteria:
  • AddedAge 18-85 years.
  • AddedNormal or corrected-to-normal vision and normal bilateral hearing.
  • AddedAbility to walk continuously on a treadmill without assistance for at least 30 minutes.
  • AddedVoluntary participation and provision of written informed consent.
  • AddedExclusion Criteria:
  • AddedHistory of stroke, neurological disorders affecting cognitive or motor function, or severe psychiatric illness.
  • AddedLower-limb musculoskeletal disorders, recent major injury or surgery, or other conditions that may interfere with normal walking.
  • AddedSevere cardiopulmonary disease or any unstable medical condition.
  • AddedSkull defects or cranial metallic or electronic implants that may interfere with fNIRS optode placement or signal acquisition.
  • AddedPregnancy or breastfeeding.
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Primary completion Jun 30, 2026→Dec 30, 2026
    Study completion Jul 30, 2026→Dec 30, 2026
    Eligibility 14 criteria added
    What changed in the criteria
    • AddedInclusion Criteria:
    • AddedExclusion Criteria:
    • AddedHealthy Volunteers
    • AddedInclusion Criteria:
    • AddedAge 18-85 years.
    • AddedNormal or corrected-to-normal vision and normal bilateral hearing.
    • AddedAbility to walk continuously on a treadmill without assistance for at least 30 minutes.
    • AddedVoluntary participation and provision of written informed consent.
    • AddedExclusion Criteria:
    • AddedHistory of stroke, neurological disorders affecting cognitive or motor function, or severe psychiatric illness.
    • AddedLower-limb musculoskeletal disorders, recent major injury or surgery, or other conditions that may interfere with normal walking.
    • AddedSevere cardiopulmonary disease or any unstable medical condition.
    • AddedSkull defects or cranial metallic or electronic implants that may interfere with fNIRS optode placement or signal acquisition.
    • AddedPregnancy or breastfeeding.
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06275516
Lead sponsor
First Affiliated Hospital of Chongqing Medical University
Responsible party
Dingqun Bai (Director, Clinical Professor, First Affiliated Hospital of Chongqing Medical University) — Principal investigator
First posted
Feb 23, 2024
Start date
Mar 20, 2024
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Nov 16, 2026

Study contacts

Dingqun Bai
Contact
baidingqun2014@163.com
023-89011334
Zheng Yang
Contact
zhengyangvivi@gmail.com
Dingqun Bai
study chair · First Affiliated Hospital of Chongqing Medical University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion